Skip to main content

Home/ MaRS/ Group items tagged for

Rss Feed Group items tagged

Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

Open Business: Top 150 Blogs for Entrepreneurs - 0 views

  • 100 http://blog.marsdd.com
  • Here is the list of the top 150 blogs that I find relevant for entrepreneurs in general, with a bias for high tech and social entrepreneurship and a special interest on the funding side.
  •  
    Top 150 blogs for entrepreneurs - Note MaRS made the list!
  • ...1 more comment...
  •  
    MaRS Blogs ranked 100 in the Top 150 Blogs for Entrepreneurs. The top 150 blogs contain relevant information for entrepreneurs in general, with a bias for high tech and social entrepreneurship and a special interest on the funding side.
  •  
    MaRS Blogs ranked 100 in the Top 150 Blogs for Entrepreneurs. The top 150 blogs contain relevant information for entrepreneurs in general, with a bias for high tech and social entrepreneurship and a special interest on the funding side.
  •  
    MaRS Blogs ranked 100 in the Top 150 Blogs for Entrepreneurs. The top 150 blogs contain relevant information for entrepreneurs in general, with a bias for high tech and social entrepreneurship and a special interest on the funding side.
Cathy Bogaart

100 Online Tools for Non-Profits - 0 views

  • 100 different applications to help you out with a variety of tasks from project tracking and collaboration to donor and membership management, and from building your non-profit website to tracking its effectiveness.
    • Cathy Bogaart
       
      Don't forget: * Writely (Google Docs) * Adobe Buzzword * Octopz (now sold, however, but a MaRS Client with amazing collaboration software for videos/graphics) * SpringNote - my fave
    • Cathy Bogaart
       
      Missing: * Blogger * TypePad * Moveable Type * Blojsom/Blosxom, etc. * See www.cmsmatrix.org for a more fullsome CMS listing
  • ...2 more annotations...
    • Cathy Bogaart
       
      Missing: * Vertical Response * Emma
  • Meetup (www.meetup.com) Meetup.com network makes it easy for anyone to organize a local group or find one already meeting up face-to-face. Free for individuals to create an account, join a group, or attend events. Organizers choose from three pricing plans, starting at $12/month for 12 months (a single $72 charge).
    • Cathy Bogaart
       
      Pricing: 6 months for only $12/month Save 37% Billed in one payment of $72.00 3 months for only $15/month Save 21% Billed in one payment of $45.00 1 month for only $19/month
  •  
    Note that the above are all free!
  •  
    Looking for software appropriate for your non-profit business? Here are 100 - covering ground from project tracking to collaboration to building your website.
Sarah Hickman

The Well-Designed Global R&D Network - 0 views

  •  
    Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.
Sarah Hickman

Amazon.com: In Search of the Obvious: The Antidote for Today's Marketing Mess (97804702... - 0 views

  •  
    Advertisers are criticized as people who look for the creative and edgy, not the obvious. They will not be happy.Marketing people are criticized for getting hopelessly entangled in corporate egos and complicated projects. They will not be happy.Research people are criticized for generating more confusion than clarity. They will not be happy. Some big companies are criticized for their ill-fated marketing programs or lack of proper strategy. They will not be happy.Wall Street is criticized for putting too much emphasis on growth that is unnecessary and can be destructive to a brand. They will just ignore this criticism and continue trying to make as much money as they can. But this is a book not written to make people happy but to explain to marketers what their real problem is. Only then will they begin to look for the obvious solutions that will separate their products from their competitors -- in a way that is equally obvious to customers. All this comes with no jargon, no numbers, no complexity, and a great deal of common sense.
Assunta Krehl

Cancer chief wins precursor to Nobel - National Post - April 7, 2010 - 0 views

  •  
    Calvin Stiller, chairman of the Ontario Institute for Cancer Research, won the Canada Gairdner Wightman Award for his work on the use of cyclosporine as a treatment for organ transplant rejection, but also for his role as a scientific entrepreneur, and a rainmaker for major scientific projects. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.
Assunta Krehl

Test-tube industry - Canadian Business - 0 views

  • For Dr. John Evans, growing a strong biotechnology industry is much the same: cities must provide a nurturing environment where science and business can thrive together.
  • That's why Evans, former president of the University of Toronto and current chairman of Torstar Corp., is spearheading the $345-million Medical and Related Science initiative, or MaRS--a petri dish of sorts for commercializing science research. "A lot of intellectual property is being commercialized outside Canada," says Evans. "I think we've been slow in realizing just how important technology developments are to the economic future of the country. MaRS is an attempt to give this a kick into a higher gear." The centrepiece of the MaRS plan, which will officially launch May 12, is a 1.3-million-square-foot, five-building complex in downtown Toronto that will provide office and lab space for small and medium-size companies and incubators, including the not-for-profit Toronto Biotechnology Commercialization Centre. While Evans is reluctant to limit its scope, MaRS will generally focus on health-related technologies, from new drugs and genetic treatments to medical devices and imaging software. Branded a "convergence centre," it will also house a careful mix of support services: intellectual property lawyers, accountants, marketing experts, government funding organizations and venture capital financiers. Plus, start-ups will have access to all the latest equipment on site. For instance, MaRS is in talks with MDS Sciex to supply mass spectrometers, used in proteomics research.
  • But MaRS will be more than just a New Economy real estate development. Evans's intention is to funnel tenants' rent money into services--such as entrepreneurship seminars and angel-matching programs--that MaRS will offer to the broader biotech community. That's why MaRS's location is key: the centre will be built in the heart of what Toronto has dubbed the "Discovery District," a two-square-kilometre chunk of the downtown core, encompassing U of T and four major hospitals. From there, MaRS hopes to act as a network hub across Ontario, with links to research-intensive universities. "None of them," says Evans, "have the critical mass to put it all together on their own."
  • ...3 more annotations...
  • MaRS's primary goal is to get Toronto and the rest of Ontario on the global biotech map. Evans came up with the concept in the late 1990s with Dr. Calvin Stiller, CEO of the labor-sponsored Canadian Medical Discoveries Fund, and Kenneth Knox, a former deputy minister for the Ontario government who's now CEO of MaRS
  • As far as schemes to support fledgling industries go, MaRS is refreshing. To start, it's a nonprofit corporation, not a government program, which will hopefully ensure that it runs more efficiently. The feds and the province of Ontario have each doled out $20 million for MaRS, and Toronto has donated in-kind $4.5 million. More than $12 million has come from a small pool of corporations, including Eli Lilly Canada and MDS, as well as individual donors like Joseph Rotman and Lawrence Bloomberg (who both sit on the MaRS board). U of T pitched in $5 million, and MaRS also did some innovative bond financing to round off the $165 million needed to build Phase I. "It was very important for us to not belong to anybody," says Evans.
  • Now MaRS's challenge is to get the word out. Its posted rate of $26 per square foot is very competitive for prime downtown real estate and is sure to attract attention, especially considering its customized lab space. But MaRS's success won't be measured by a low vacancy rate; getting the right mix of scientists, entrepreneurs and professionals is critical if it plans to commercialize some sustainable businesses. It won't happen overnight--in fact, it may be 10 years before anyone can gauge MaRS's impact. Seems growing a biotech industry isn't quite as easy as growing E. coli in a petri dish.
  •  
    John Evans spearheads the MaRS project which will help to accelerate commercialization for scientific research. The official launch of the MaRS plan will happen on May 12, 2003.
Cathy Bogaart

Social Enterprise Gains Importance In Tough Times - The Leader World - 0 views

  • with self-belief and a preparedness to adapt to the new economic situation, social enterprise will thrive
  • Social enterprise, in many ways, is about generating value: for both society and business. What could be more important when facing difficult times?
  • leverage their natural resources for the betterment of both society and their bottom line
  • ...2 more annotations...
  • New graduates are known as ‘Generation Yers’. Born between 1979 and 1998, they want to be successful business people, but they also want to do good with their skills. They want luxurious products, but won’t buy from unethical companies. For businesses to recruit and retain the best, they have to offer more than the corporate package. Community engagement is fast becoming a key competitive differentiator between professional services firms. In a recent survey of UK graduates by PricewaterhouseCoopers, 70% said that they will actively seek out employers whose corporate responsibility behaviour reflects their own. An Aspen Institute study shows business school students citing ‘business's responsibility to society’ as a top concern when choosing a job.
  • social entrepreneurship will be rattled by this economic situation, but we will make changes to our approach where necessary and come out stronger and more central to both business and community.
  •  
    This article talks about how the recession's economic tightening is actually good for social enterprises as it forces the industry to be more innovative in order to survive. The author talks about asking for partnerships that are even more valuable than charitable donations. He also talks about why it's important for all companies to incorporate ethical business practices in order to stay viable in a generation of people who care deeply about where products come from. Times are better than ever for social entrepreneurs.
Assunta Krehl

Go to MaRS - Canadian Newcomers Magazine - 0 views

  • nd development of new ideas. It provides not only office and lab space but also free mentoring assistance to new businesses in science, technology and social innovation. While there are probably no chickens hatching at MaRS, it wouldn't be at all surprising to find a company working on, say, a vaccine for bird flu. Approximately 20 incubator companies are currently housed at MaRS, including Clera Inc. - which is developing treatments for schizophrenia and depression; AXS Biomedical Animations Studio - a company that creates 3D medical animation for biomedical research and other applications; and Kanata Chemical Technologies (KCT), which has had great success developing catalysts for the chemical industry (catalysts speed up chemical reactions without being changed or consumed in those reactions
  • All of the above definitions could apply to the wider innovation community connected with the MaRS Centre. Located in the heart of Toronto's Discovery District - a 2.5 sq. kilometre downtown research district, MaRS is a non-profit environment for the birt
  • KCT founder and president Kamal Abdur-Rashid came to Canada in 1997 with a degree from the University of the West Indies
  • ...5 more annotations...
  • With support from the Mississauga Technology Business Accelerator (MTBA) he started his business, which grew to occupy some state-of-the-art labs at MaRS and is about to take the next step forward by moving its business outside of the protecting and nurturing environment of MaRS. This is the entire purpose of MaRS, which says on its website (www.marsdd.com), "We measure our success through the companies that emerge after receiving help from MaRS." "The resources, the facilities, the training and everything else that MaRS is bringing to the table - we're able to capitalize on that and get off on a very solid footing," says Kamal. Inside the Incubato
  • Whether you're looking for work - or you want to start your own business, MaRS is one of the best places to start your search.
  • Everybody you talk to in the elevator, the hall, the cafeteria - they are all in the science field - so you can network with one another," says Ratheesh. "MaRS does not just provide research space, they are bringing business people, people with money." These are the connections that can turn your idea into a profit-making business that employs many people. This is exactly what MaRS is all about. As they say on their website, "MaRS connects the communities of science, business and capital and fosters collaboration among them." MaRS advisors are able to connect entrepreneurs with private funding opportunities as well as free educational programming and hands-on advisory services. Corporate sponsor CIBC funds an entrepreneurship lecture series, for example. Ratheesh adds, "Patent people are here as well, so if you have patentable technology, you can talk to them." Once you start your business, MaRS offers many supports. "When we had the lab space we had the chemical hood that had to be set up so MaRS came and provided people to set up our hood," explains Ratheesh. "They help us dispose of chemical waste, provide water service, fridge and freezer service - so these are all important. "For smaller companies that have problem buying fridges and freezers, they can use common equipment." MaRS facilities also include lecture theatres, meeting rooms and an auditorium. Growing Cultures Bacteria and tissue cultures aren't the only cultures that thrive in the MaRS environment. It's also a great place for newcomers from every culture to
  • Clera, one of many emerging companies housed in the MaRS incubator.
  • He says, "MaRS is a one-stop shop for job and information seekers. Here we have many companies - so quite a few job opportunities
  •  
    A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories. Jan/Feb 2009
  •  
    A look at Canadian immigrants who started a business and are incubating at the MaRS Centre. KCT and Clera, MaRS Tenants tell their stories.
Assunta Krehl

U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics in Order t... - 0 views

  •  
    The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. Parimal Nathwani, Vice President of MaRS Innovation, says"Forums like this represent an excellent opportunity for reviewing technologies and supporting collaboration across different institutions for more effective translation and commercialization opportunity."
Sarah Hickman

Amazon.com: The Innovator's Solution: Creating and Sustaining Successful Growth (978157... - 0 views

  •  
    From Publishers Weekly\nChristensen (The Innovator's Dilemma) analyzes the strategies that allow corporations to successfully grow new businesses and outpace the other players in the marketplace. Christensen's earlier book examined how focusing on profits can destroy even well-run corporations, while this book focuses on companies expanding by being "disruptors" who are able to outpace their entrenched competition. The authors (Christensen is a professor at Harvard Business School and Raynor, a director at Deloitte Research) examine the nine business decisions integral to growth, including product development, organizational structure, financing and key customer base. They cite such companies as IBM, AT&T, Sony, Microsoft and others to illustrate their points. Generally, the writing is clear and specific. For example, in discussing whether a company has the resources necessary for growth, the authors say, "In order to be confident that managers have developed the skills required to succeed at a new assignment, one should examine the sorts of problems they have wrestled with in the past. It is not as important that managers have succeeded with the problem as it is for them to have wrestled with it and developed the skills and intuition for how to meet the challenge successfully the next time around"; they then provide a real-life example of a software company. Similar important strategies give readers insights that they can use in their own workplaces. People looking for quick fixes may find the charts, diagrams and extensive footnotes daunting, but readers familiar with more technical business management tomes will find this one both stimulating and beneficial.
Cathy Bogaart

The Hard Work of Measuring Social Impact - HBS Working Knowledge - 0 views

  •  
    Donors are placing nonprofits on the hot seat to measure social performance. Problem is, there is little agreement on what those metrics should be. Professor Alnoor Ebrahim on how nonprofit managers should respond. Key concepts include: * Rather than simply complying with the demands of the most powerful actors, nonprofit leaders need to focus their attention on accountabilities that really matter for achieving their missions. * Measuring results is valuable as a discipline for nonprofit managers, even if they don't find universal metrics for social impact. * We might not see agreement on a common set of metrics in the social sector for a while, but could see a convergence on what constitutes critical reflective learning processes within the organization.
Assunta Krehl

MaRS Innovation selects umbilical cord stem cell technology from Samuel Lunenfeld Resea... - 0 views

  • MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are pleased to announce that they have entered into an agreement to collaboratively initiate commercialization of an umbilical cord stem cell technology for potential treatment in cardiovascular disease, diabetes and neurological disorders.
  • With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialization opportunity,” said Dr. Rafi Hofstein, President and CEO of MaRS Innovation.
  • MaRS Innovation, along with the inventors and Mount Sinai, will initially focus on the diabetes application for the technology, as research has demonstrated that these cells uniquely secrete insulin in response to glucose, thereby mimicking the “normal” physiological state.
  • ...5 more annotations...
  • The technology – invented by Mount Sinai scientists Dr. Ian Rogers and Dr. Robert Casper – offers a proprietary method to create multi-potent stem cells (MPSCs) from human umbilical cord blood.
  • With MaRS Innovation's participation, we are optimistic we will succeed."
  • Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions." With the launch of this first exciting opportunity, MaRS Innovation has embarked on a journey to transform the Toronto-based research enterprise into a successful commercialization cluster.
  • MaRS Innovation is building its own internal infrastructure to support intellectual property and market due diligence to identify the most promising commercial opportunities. MaRS Innovation is dedicated to converting the outstanding science of its member institutions into products and services, making a significant contribution to Canada’s future economic outlook and the quality of life for Canadians and others around the world
  • “We are deeply committed to creating a powerful engine for commercialization that brings together an experienced team to identify and validate market opportunities, develop technologies to market requirements and build the linkages that will advance the exceptional research of all of our institutional members,” added Dr. Hofstein. “We look forward to announcing additional technologies to add to our pipeline over the next several weeks.”
  •  
    MaRS Innovation and the Samuel Lunenfeld Research Institute of Mount Sinai Hospital are announce that they have entered into an agreement to collaboratively initiate commercialization of an umbilical cord stem cell technology for potential treatment in cardiovascular disease, diabetes and neurological disorders.
Cathy Bogaart

Public Inc - 0 views

  • PUBLIC is a for-profit, social-purpose business focused exclusively on advancing the public good. We are an innovation company, generating positive social impact through the creation of scalable programs, products and campaigns that: raise money for charitable purposes increase civic and community engagement advance social causes and issues create new social norms We bring an integrated, impact- driven approach to mobilizing and advancing the public good by aligning brand awareness, policy influence and fundraising. For us, “advancing the public good” is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
  • generating positive social impact through the creation of scalable programs, products and campaigns
  • advancing the public good” is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
  •  
    An interesting Toronto-based social-purpose business. PUBLIC is a for-profit, social-purpose business focused exclusively on advancing the public good. We are an innovation company, generating positive social impact through the creation of scalable programs, products and campaigns that: * raise money for charitable purposes * increase civic and community engagement * advance social causes and issues * create new social norms We bring an integrated, impact- driven approach to mobilizing and advancing the public good by aligning brand awareness, policy influence and fundraising. For us, "advancing the public good" is about motivating people (and organizations) to behave in ways that benefit society while recognizing and appealing to their self-interest.
Assunta Krehl

Federal Commission's support for pay-as-you-drive to renew aging infrastructure poses..... - 0 views

  • U.S. commission report released today underscores the need for a nationwide pay-as-you-drive system - a system akin to one refined and tested worldwide by upstart tech firm Skymeter Corp.
  • Skymeter as its technical solution partner of choice for 'Smart Transportation Pricing' technology in the city of Seoul under the Connected Urban Development program.
  • Skymeter solution solves severe GPS signal problems among numerous intersecting and parallel side-roads and offers a high degree of billing accuracy, critical to system acceptance. Skymeter is currently being tested in San Francisco against what are considered to be the best GPS receivers in North America. The results of these tests to date mirror successful European and Asian trials of Skymeter's system.
  • ...2 more annotations...
  • "The Commission has hit the bull's eye with its recommendations", says Skymeter CEO Kamal Hassan. "Recognizing and recommending sensible policy using reliable and cost-effective technology addresses the three evils plaguing surface transportation: under-funding, CO(2) emissions, and traffic jams." Hassan says that by opting for a sensibly-designed GPS-driven user fee system America's total CO(2) emissions will be reduced by 5% or 350 million metric tonnes, the same reduction as if one out of every four cars on the road were replaced by electric cars. It will also make the average commute around 10% faster. "Those are pretty good side effects for a system that returns the nation's road financing system to health" says Hassan.
  • Skymeter Corporation is a Toronto, Canada-based data services operator that enables location-based payments using financial-grade GPS telematics. Its billing-delivery services include Vehicle Miles Traveled (VMT) metering for road use, parking and PAYD insurance. These services incorporate methodologies for both privacy and anonymity to ensure motorists enjoy complete privacy while traveling and absolute confidentiality of their trips. Skymeter is equivalent to an anonymous, in-car cell-phone that automatically pays for all transport services based on actual usage. Skymeter enables every form of road-use charging from small city areas such as London and Stockholm's cordon charges up to metering every vehicle in a state, province or country in order to replace fuel taxes.
  •  
    U.S. commission report released states that there is a need\nfor a nationwide pay-as-you-drive system - a system that is similar to Skymeter Corp which is an upstart tech firm and a MaRS Tenant. Skymeter technicial solution solves the severe GPS signal problems as is currently being tested in North America. Feb 26, 2009
  •  
    U.S. commission report released states that there is a need for a nationwide pay-as-you-drive system - a system that is similar to Skymeter Corp which is an upstart tech firm and a MaRS Tenant. Skymeter technicial solution solves the severe GPS signal problems as is currently being tested in North America.
Sarah Hickman

MaRS Discovery District - Recommended Resources - Social Innovation - Centre for Social... - 0 views

  •  
    "The Centre for Social Innovation is a place-based hub of ideas, people, services and strategies. In partnership with Urbanspace Property Group, they provide 18,000 square feet of shared workspace in downtown Toronto. The Centre for Social Innovation is home to a community of nonprofits, charities, social enterprises, artists, green businesses, and individual innovators. Working together, they lower costs, create synergies, and spark new ideas for advancing their shared interests. The Centre for Social Innovation explores new ideas in collaboration, social entrepreneurship and systems change. These interests guide their work. Their website only offers a subscription to their email newsletter, Social Innovator's Update. Join to receive information on news and events in this space."
Assunta Krehl

U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics ... - 0 views

  •  
    The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. MaRS Innovation is one of the supporters for the conference.
Assunta Krehl

The business side to good health - The Star - 0 views

  • The Ivey Centre for Health Innovation and Leadership was launched this year with a $5-million push from the Canadian government. The latest Ivey initiative has the goal of bringing students together with experts from the science and business sectors, with the ultimate goal of better identifying and commercializing health technologies.Dr. Kellie Leitch, a Hospital for Sick Children orthopedic surgeon, is the first executive director of the centre, which is based at Western.
  • She is sitting in the basement of MaRS, a scientific hub of activity in downtown Toronto where labs, business and major Toronto teaching hospitals are brought together under one roof.
  • The Ivey centre will focus on giving the educational capability to our students so they become really well educated in innovation and commercialization, so we can keep things here at home in Canada and grow those products."
  • ...2 more annotations...
  • A good example of where both business and health-care expertise is needed is at Crown agencies such as eHealth Ontario.
  • The new Ivey centre builds on a partnership with the London Health Sciences Centre and the Schulich School of Medicine and Dentistry
  •  
    The Ivey Centre for Health Innovation and Leadership was launched in 2009. The goal of this initiative is to bring students together together with experts from the science and business sectors, with the ultimate goal of better identifying and commercializing health technologies.Dr. Kellie Leitch, a Hospital for Sick Children orthopedic surgeon, is the first executive director of the centre, which is based at Western. Sept 10, 2009
Sarah Hickman

Research and Policy at the Kauffman Foundation - 0 views

  •  
    As a site of the Kauffman Foundation, this portal provides links to entrepreneurship and technology commercialization publications including 742 journals, 197 books, 70 reports, 73 conferences, and 116 working-papers. All publications are summarized via free access to their abstract, however access to their full-text depends entirely on their publisher/vendor: some are free, some are pay per view, and some require paid subscription. The portal provides direct linking to full-text if available. Since the portal operates on strict headings, it provides excellent access to publications. Since it links to several citation softwares, it is an excellent resource for those looking to compile lists of references. Otherwise, it is an excellent resource for entrepreneurs wanting to keep up with entrepreneurial research and findings, as well as for those wanting to publish entrepreneurial written work. For an example of what can be found on the portal, download the full text version of "The Entrepreneurial Spawing of Scientists and Engineers: Stars, Slugs, and the Small Firm Effect".
Sarah Hickman

Amazon.com: Hidden in Plain Sight: How to Find and Execute Your Company's Next Big Grow... - 0 views

  •  
    From Booklist: Joachimsthaler offers another book that promotes use of reinvented basic marketing principles to assist highly innovative companies. The author describes his DIG model (Demand-First Innovation & Growth), which consists of three interlinked parts: explore the demand for their products and services through an in-depth understanding of how people behave and live their lives and how they consume; apply an innovative routine of structured thinking to identify opportunities that customers cannot articulate; and formulate a strategy for effectively pursuing new opportunities. We learn that although most companies conduct some type of market research, they may fail to look for real opportunities and quantify them or fail to develop viable action plans that lead to results. This model illustrates how to become an unbiased observer of people's consumption and usage behaviors and offers a new approach to identifying and executing a company's growth strategy. Joachimsthaler, a consultant, reports that "successful opportunities for innovation and growth are right here, in front of us, and we often can't see them or don't act on them." Mary Whaley Copyright © American Library Association. All rights reserved
1 - 20 of 724 Next › Last »
Showing 20 items per page